4368 — Fuso Chemical Co Balance Sheet
0.000.00%
- ¥126bn
- ¥118bn
- ¥59bn
- 90
- 52
- 88
- 91
Annual balance sheet for Fuso Chemical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 16,566 | 25,707 | 24,360 | 23,413 | 31,472 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 10,266 | 10,537 | 14,873 | 14,954 | 16,445 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 35,500 | 45,131 | 52,078 | 55,344 | 68,134 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 28,891 | 25,924 | 35,291 | 54,302 | 59,027 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 69,223 | 76,032 | 92,010 | 113,529 | 133,740 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 7,097 | 7,836 | 14,667 | 23,909 | 16,457 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 8,933 | 9,863 | 16,706 | 26,026 | 38,715 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 60,289 | 66,170 | 75,303 | 87,503 | 95,025 |
Total Liabilities & Shareholders' Equity | 69,223 | 76,032 | 92,010 | 113,529 | 133,740 |
Total Common Shares Outstanding |